Sterile medical instrument charging device

Information

  • Patent Grant
  • 11744635
  • Patent Number
    11,744,635
  • Date Filed
    Monday, February 3, 2020
    4 years ago
  • Date Issued
    Tuesday, September 5, 2023
    8 months ago
Abstract
A system includes a medical device and a charging device. A sterile barrier may be interposed between the medical device and the charging device. The medical device includes an integral power source and an active element. The charging device is configured to charge the integral power source. The charging device may charge the integral power source through direct contact between features of the charging device and features the medical device. The charging device may alternatively charge the integral power source wirelessly, such as through inductive coupling. The medical device may include conductive prongs that are retained by the charging device. The charging device may physically couple with the medical device via magnets. The medical device and the charging device may be provided together in a sterile package as a kit. The kit may also include a reclamation bag to facilitate reclamation of electrical components.
Description
BACKGROUND

With the advancement of the electronics industry, many medical devices that rely on some form of electric power may be adapted to contain most, if not all, of the required components within the medical device. More specifically, some medical devices may be adapted to use an internal or attachable power source instead of requiring the device to be plugged into an external power source by a cable. Merely exemplary devices that may be adapted to include a portable power source are disclosed in U.S. Pat. No. 6,500,176 entitled “Electrosurgical Systems and Techniques for Sealing Tissue,” issued Dec. 31, 2002, the disclosure of which is incorporated by reference herein; U.S. Pat. No. 7,416,101 entitled “Motor-Driven Surgical Cutting and Fastening Instrument with Loading Force Feedback,” issued Aug. 26, 2008, the disclosure of which is incorporated by reference herein; U.S. Pat. No. 7,738,971 entitled “Post-Sterilization Programming of Surgical Instruments,” issued Jun. 15, 2010, the disclosure of which is incorporated by reference herein; U.S. Pub. No. 2006/0079874 entitled “Tissue Pad for Use with an Ultrasonic Surgical Instrument,” published Apr. 13, 2006, now abandoned, the disclosure of which is incorporated by reference herein; U.S. Pub. No. 2007/0191713 entitled “Ultrasonic Device for Cutting and Coagulating,” published Aug. 16, 2007, the disclosure of which is incorporated by reference herein; U.S. Pub. No. 2007/0282333 entitled “Ultrasonic Waveguide and Blade,” published Dec. 6, 2007, now abandoned, the disclosure of which is incorporated by reference herein; U.S. Pub. No. 2008/0200940 entitled “Ultrasonic Device for Cutting and Coagulating,” published Aug. 21, 2008, now abandoned, the disclosure of which is incorporated by reference herein; U.S. Pub. No. 2009/0209990 entitled “Motorized Surgical Cutting and Fastening Instrument Having Handle Based Power Source,” published Aug. 20, 2009, (now U.S. Pat. No. 8,657,174, issued Feb. 25, 2014), the disclosure of which is incorporated by reference herein; and U.S. Pub. No. 2010/0069940 entitled “Ultrasonic Device for Fingertip Control,” published Mar. 18, 2010, (now U.S. Pat. No. 9,023,071, issued May 5, 2015), the disclosure of which is incorporated by reference herein. Similarly, various ways in which medical devices may be adapted to include a portable power source are disclosed in U.S. Provisional Application Ser. No. 61/410,603, filed Nov. 5, 2010, entitled “Energy-Based Surgical Instruments,” the disclosure of which is incorporated by reference herein.


Electrically powered medical devices such as those referred to herein may require an internal or otherwise integral power source (e.g., a battery or battery pack, etc.) to be charged or recharged immediately before use, during use, or otherwise. In some settings (e.g., those where a charging device is re-used several times, etc.), it may be desirable to provide some degree of isolation between a charging device and the medical device to thereby reduce the likelihood that the charging device will contaminate the medical device and/or to reduce the likelihood that the medical device will contaminate the charging device. Similarly, it may be desirable to facilitate charging or recharging of the power source within relatively close proximity to the location at which the medical device will be used in a medical procedure (e.g., within an operating room, etc.). While several systems and methods have been made and used to charge or recharge power sources, it is believed that no one prior to the inventors has made or used the invention described in the appended claims.





BRIEF DESCRIPTION OF THE DRAWINGS

While the specification concludes with claims which particularly point out and distinctly claim this technology, it is believed this technology will be better understood from the following description of certain examples taken in conjunction with the accompanying drawings, in which like reference numerals identify the same elements and in which:



FIG. 1 depicts a schematic view of an exemplary medical device having an internal power source;



FIG. 2 depicts a perspective view of an exemplary medical device having an internal power source;



FIG. 3 depicts a perspective view of an exemplary medical device system including a cable and battery combination;



FIG. 4 depicts a partial cross-sectional view of a cable connector of the system of FIG. 3;



FIG. 5 depicts an exemplary medical device with components in a packaging system;



FIG. 6 depicts the system of FIG. 5 with battery components being charged in the packaging;



FIG. 7 depicts a perspective view of the medical device of FIG. 5 with a battery and control module positioned for insertion in the medical device;



FIG. 8 depicts a partial cross-sectional view of the medical device of FIG. 5 ejecting the control module;



FIG. 9 depicts a perspective view of a reclamation bag of the system of FIG. 5 holding electronic components of the system of FIG. 5;



FIG. 10 depicts an exploded view of exemplary medical device recharging assembly;



FIG. 11 depicts a perspective view of a medical device positioned over the recharging assembly of FIG. 10;



FIG. 12 depicts a partial cross-sectional view of the medical device of FIG. 11 coupled with the recharging assembly of FIG. 10;



FIG. 13A depicts a partial cross-sectional view of another exemplary medical device recharging assembly, with a medical device positioned over the recharging assembly;



FIG. 13B depicts a partial cross-sectional view of the recharging assembly of FIG. 13A, with the medical device being coupled with the recharging assembly;



FIG. 13C depicts a partial cross-sectional view of the recharging assembly of FIG. 13A, with the medical device removed and leaving behind recharging prongs;



FIG. 14 depicts a schematic diagram of an exemplary wireless recharging system with wireless data communication;



FIG. 15 depicts a perspective view of an exemplary version of a charging station provided in accordance with the system of FIG. 14;



FIG. 16 depicts a perspective view of another exemplary version of a charging station provided in accordance with the system of FIG. 14;



FIG. 17 depicts a schematic view of an exemplary inductive charging pad system;



FIG. 18 depicts a perspective view of an exemplary inductive charging peg system;



FIG. 19 depicts a partial cross-sectional view of the charging peg system of FIG. 18, including a coupled medical device; and



FIG. 20 depicts an exemplary medical device powered by supercapacitors, with a charging pad draped over a patient.





The drawings are not intended to be limiting in any way, and it is contemplated that various embodiments of the technology may be carried out in a variety of other ways, including those not necessarily depicted in the drawings. The accompanying drawings incorporated in and forming a part of the specification illustrate several aspects of the present technology, and together with the description serve to explain the principles of the technology; it being understood, however, that this technology is not limited to the precise arrangements shown.


DETAILED DESCRIPTION

The following description of certain examples of the technology should not be used to limit its scope. Other examples, features, aspects, embodiments, and advantages of the technology will become apparent to those skilled in the art from the following description, which is by way of illustration, one of the best modes contemplated for carrying out the technology. As will be realized, the technology described herein is capable of other different and obvious aspects, all without departing from the technology. Accordingly, the drawings and descriptions should be regarded as illustrative in nature and not restrictive.


I. Medical Devices for Use with Insertable or Reclaimable Components


FIG. 1 shows components of an exemplary medical device (10) in diagrammatic block form. As shown, medical device (10) comprises a control module (12), a power source (14), and an end effector (16). Merely exemplary power sources (14) may include NiMH batteries, Li-ion batteries (e.g., prismatic cell type lithium ion batteries, etc.), Ni-Cad batteries, or any other type of power source as may be apparent to one of ordinary skill in the art in light of the teachings herein. Control module (12) may comprise a microprocessor, an application specific integrated circuit (ASIC), memory, a printed circuit board (PCB), a storage device (such as a solid state drive or hard disk), firmware, software, or any other suitable control module components as will be apparent to one of ordinary skill in the art in light of the teachings herein. Control module (12) and power source (14) are coupled by an electrical connection (22), such as a cable and/or traces in a circuit board, etc., to transfer power from power source (14) to control module (12). Alternatively, power source (14) may be selectively coupled to control module (12). This allows power source (14) to be detached and removed from medical device (10), which may further allow power source (14) to be readily recharged or reclaimed for resterilization and reuse, such as in accordance with the various teachings herein. In addition or in the alternative, control module (12) may be removed for servicing, testing, replacement, or any other purpose as will be apparent to one of ordinary skill in the art in view of the teachings herein.


End effector (16) is coupled to control module (12) by another electrical connection (22). End effector (16) is configured to perform a desired function of medical device (10). By way of example only, such function may include cauterizing tissue, ablating tissue, severing tissue, ultrasonically vibrating, stapling tissue, or any other desired task for medical device (10). End effector (16) may thus include an active feature such as an ultrasonic blade, a pair of clamping jaws, a sharp knife, a staple driving assembly, a monopolar RF electrode, a pair of bipolar RF electrodes, a thermal heating element, and/or various other components. End effector (16) may also be removable from medical device (10) for servicing, testing, replacement, or any other purpose as will be apparent to one of ordinary skill in the art in view of the teachings herein. In some versions, end effector (16) is modular such that medical device (10) may be used with different kinds of end effectors (e.g., as taught in U.S. Provisional Application Ser. No. 61/410,603, etc.). Various other configurations of end effector (16) may be provided for a variety of different functions depending upon the purpose of medical device (10) as will be apparent to those of ordinary skill in the art in view of the teachings herein. Similarly, other types of components of a medical device (10) that may receive power from power source (14) will be apparent to those of ordinary skill in the art in view of the teachings herein.


Medical device (10) of the present example includes a trigger (18) and a sensor (20), though it should be understood that such components are merely optional. Trigger (18) is coupled to control module (12) and power source (14) by electrical connection (22). Trigger (18) may be configured to selectively provide power from power source (14) to end effector (16) (and/or to some other component of medical device (10)) to activate medical device (10) when performing a procedure. Sensor (20) is also coupled to control module (12) by an electrical connection (22) and may be configured to provide a variety of information to control module (12) during a procedure. By way of example only, such configurations may include sensing a temperature at end effector (16) or determining the oscillation rate of end effector (16). Data from sensor (20) may be processed by control module (12) to effect the delivery of power to end effector (16) (e.g., in a feedback loop, etc.). Various other configurations of sensor (20) may be provided depending upon the purpose of medical device (10) as will be apparent to those of ordinary skill in the art in view of the teachings herein. Of course, as with other components described herein, medical device (10) may have more than one sensor (20), or sensor (20) may simply be omitted if desired.



FIG. 2 depicts a merely exemplary form that medical device (10) may take. In particular, FIG. 2 shows a medical device (100) comprising a power source (110), a control module (120), a housing (130), end effector (140), and an electrical connection (150). In the present example, power source (110) is located internally within housing (130) of medical device (100). Alternatively, power source (110) may only partially extend into housing (130) and may be selectively attachable to a portion of housing (130). In yet a further exemplary configuration, a portion of housing (130) may extend into power source (110) and power source (110) may be selectively attachable to the portion of housing (130). Power source (110) may also be configured to detach from medical device (100) and decouple from control module (120) or electrical connection (150). As a result, power source (110) may be completely separated from medical device (100) in some versions. As is readily apparent, this may allow the power source (110) to be removed to be recharged or reclaimed for resterilization and reuse, such as in accordance with various teachings herein. After recharging, or after an initial charge, power source (110) may be inserted or reinserted into medical device (100) and secured to housing (130) or internally within housing (130). Of course, medical device (100) may also allow power source (110) to be charged and/or recharged while power source (110) is still in or otherwise coupled relative to housing (130).


It should also be understood that control module (120) may be removed for servicing, testing, replacement, or any other purpose as will be apparent to one of ordinary skill in the art in view of the teachings herein. Further, end effector (140) may also be removable from medical device (100) for servicing, testing, replacement, or any other purpose as will be apparent to one of ordinary skill in the art in view of the teachings herein. While certain configurations of an exemplary medical device (100) have been described, various other ways in which medical device (100) may be configured will be apparent to those of ordinary skill in the art in view of the teachings herein. By way of example only, medical devices (10, 100) and/or any other medical device referred to herein may be constructed in accordance with at least some of the teachings of U.S. Pat. Nos. 6,500,176; 7,416,101; 7,738,971; U.S. Pub. No. 2006/0079874, now abandoned; U.S. Pub. No. 2007/0191713, now abandoned; U.S. Pub. No. 2007/0282333, now abandoned; U.S. Pub. No. 2008/0200940, now abandoned; U.S. Pub. No. 2009/0209990 (now U.S. Pat. No. 8,657,174); U.S. Pub. No. 2010/0069940 (now U.S. Pat. No. 9,023,071); and/or U.S. Provisional Application Ser. No. 61/410,603.


It is further understood that any one or more of the teachings, expressions, embodiments, examples, etc. described herein may be combined with any one or more of the other teachings, expressions, embodiments, examples, etc. that are described herein. The following-described teachings, expressions, embodiments, examples, etc. should therefore not be viewed in isolation relative to each other. Various suitable ways in which the teachings herein may be combined will be readily apparent to those of ordinary skill in the art in view of the teachings herein. Such modifications and variations are intended to be included within the scope of the claims.


It should also be understood that various teachings herein may be readily combined with various teachings in any of the following patent applications, all of which are filed on even date herewith and the disclosures of all of which are incorporated by reference herein: U.S. patent application Ser. No. 13/151,471, entitled “Medical Device Packaging with Charging Interface,” published May 10, 2012 as U.S. Pub. No. 2012/0112690, issued as U.S. Pat. No. 9,000,720 on Apr. 7, 2015; U.S. patent application Ser. No. 13/151,481, entitled “Motor Driven Electrosurgical Device with Mechanical and Electrical Feedback,” issued as U.S. Pat. No. 9,161,803 on Oct. 20, 2015; U.S. patent application Ser. No. 13/151,488, entitled “Packaging for Reclaimable Component of a Medical Device,” published May 10, 2012 as U.S. Pub. No. 2012/0111591, now abandoned; U.S. patent application Ser. No. 13/151,498, entitled “Sterile Housing for Non-Sterile Medical Device Component,” issued a U.S. Pat. No. 9,017,851 on Apr. 28, 2015; U.S. patent application Ser. No. 13/151,509, entitled “Medical Device Packaging with Window for Insertion of Reusable Component,” issued as U.S. Pat. No. 9,089,338 on Jul. 28, 2015; U.S. patent application Ser. No. 13/151,512, entitled “Medical Device with Feature for Sterile Acceptance of Non-Sterile Reusable Component,” issued as U.S. Pat. No. 9,072,523 on Jul. 7, 2015; and U.S. patent application Ser. No. 13/151,515, entitled “Sterile Package System for Medical Device,” issued as U.S. Pat. No. 10,080,813 on Sep. 25, 2018. Various suitable ways in which teachings herein may be combined with teachings of the above-referenced patent applications, as well as various ways in which teachings of the above-referenced patent applications may be combined together with or without teachings herein, will be apparent to those of ordinary skill in the art.


II. Exemplary Medical Device System Including Combined Integral Power Source and External Power Source


FIG. 3 shows an exemplary medical device (200) that includes an integral power source (218) and that also relies on external power. Medical device (200) of this example includes a handpiece (210), an end effector (212) disposed at the distal end of a shaft (214), and a trigger (216). Integral power source (218) is included within the handpiece (210) and selectively activates end effector (212) in accordance with actuations of trigger (216). By way of example only, end effector (212) may comprise a harmonic blade, a pair of clamping jaws, and/or one or more electrosurgical elements. It should be understood that medical device (200) may be constructed and operable in accordance with medical device (10, 100) and/or in accordance with at least some of the teachings of any of the references cited herein. Various other kinds of devices to which the teachings of medical device (200) may be applied will be apparent to those of ordinary skill in the art in view of the teachings herein.


In the present example, integral power source (218) includes a single battery. In particular, integral power source (218) in this example provides enough power in a single charge to activate end effector (212) one or more times during a normal use of medical device (200) in a medical procedure. However, integral power source (218) in this example does not necessarily provide enough power to activate end effector (212) as many times as needed during a normal use of medical device (200) in a medical procedure without providing at least some degree of recharging of integral power source (218). To that end, a relatively thin charging wire (230) is coupled with handpiece (210) at coupling (220). Charging wire (230) is also coupled with an adapter (232), which is further coupled with a conventional power cable (234). Power cable (234) is plugged into a conventional wall outlet (236), though it should be understood that charging wire (230), adapter (232), and/or power cable (234) may alternatively be coupled with a piece of capital equipment and/or some other component.


Charging wire (230) is operable to deliver enough power to integral power source (218) to sufficiently charge integral power source (218) during a normal use of medical device (200) in a medical procedure. However, in the present example, charging wire (230) does not have sufficient thickness to provide all power needed to activate end effector (212) during normal use of medical device (200) in a medical procedure. Thus, charging wire (230) and integral power source (218) work in tandem—with integral power source (218) being the primary power source for end effector (212) and with charging wire (230) being used to recharge integral power source (218) (e.g., between selective activations of end effector (212), etc.).


Charging wire (230) of the present example is also substantially thinner than conventional power cable (234). It should be understood that this may provide greater mobility for medical device (200) due to reduced weight pulling on handpiece (210), particularly if adapter (232) and cable (234) rest on the floor. As is also shown in FIG. 3, power cable (234) and adapter (232) are located in a non-sterile field (240) while charging wire (230) and the rest of medical device (200) are located in a sterile field (250) in the present example. It should be understood that this may facilitate re-use of power cable (234) and adapter (232) in various medical procedures with various medical devices (200), without having to re-sterilize power cable (234) and adapter (232) for each re-use. Of course, it may still be desirable to sterilize charging wire (230) and the rest of medical device (200) before medical device (200) is used in a medical procedure, regardless of whether charging wire (230) and/or other parts of medical device (200) are re-used in subsequent medical procedures. In instances where charging wire (230) and medical device (200) are provided in a sterile kit before use, integral power source (218) may be provided with a partial charge in the kit.


In some versions, using a single battery for integral power source (218) may help reduce the overall cost and weight of medical device (200). In other words, using a larger integral power source (218) that is capable of activating end effector (212) enough times during normal use of medical device (200) without such a power source (218) having to be recharged might result in a more expensive and/or heavier medical device (200). Of course, integral power source (218) may comprise more than one battery or may even comprise some kind of power source other than a battery. Furthermore, integral power source (218) may be configured to hold enough charge sufficient to activate end effector (212) enough times during normal use of medical device (200) without such a power source (218) having to be recharged.



FIG. 4 shows coupling (220) of the present example in greater detail. As shown, coupling (220) a first magnet (222) integral with handpiece (210) and a second magnet (224) integral with a strain relief (226) on wire (230). In the present example, magnets (222, 224) provide relatively quick and easy coupling/decoupling of wire (230) and handpiece (210). In some versions, handpiece (210) and wire (230) also present complementary contacts, prongs and sockets, and/or other features to provide electrical communication from wire (230) to integral power source (218). Magnets (222, 224) may be located adjacent to such electrical communication features. Handpiece (210) and/or wire (230) may also include one or more bosses or other guide features configured to facilitate proper coupling of wire (230) with handpiece (210). It should also be understood that magnets (222, 224) are merely optional, and that a variety of other types of features may be used, including but not limited to latches, clamps, clips, friction fittings, etc.


In some instances, a surgeon may wish to decouple wire (230) from handpiece (210) to provide greater mobility or positioning of medical device (200). In such instances, wire (230) may be readily re-coupled with handpiece (210) at coupling (220), even in the operating room, to provide any additional charge that may be needed for integral power source (218) after one or more activations of end effector (212). Furthermore, handpiece (210) or some other component of medical device (200) may include a charge indicator, providing a visual and/or audio indication of the charge state of power source (218), thereby alerting the surgeon to when power source (218) needs to be recharged. Still other suitable components, features, configurations, and operabilities of medical device (200) will be apparent to those of ordinary skill in the art in view of the teachings herein.


III. Exemplary Medical Device Kit Including Electronic Component Charging and Reclamation Features


FIGS. 5-9 show an exemplary kit (300) and its various components, including a medical device (310), batteries (320), a control module (330) (e.g., printed circuit board, generator board, etc.), and a reclamation bag (340), all of which are positioned in respective compartments of packaging (350). Packaging (350) of the present example comprises a sterile blister pack, though it should be understood that packaging (350) may take any other suitable form. In some versions, packaging (350) is constructed in accordance with the teachings of U.S. patent application Ser. No. 13/151,515, entitled “Sterile Package System for Medical Device,” filed Jun. 2, 2011, issued as U.S. Pat. No. 10,080,813 on Sep. 25, 2018, the disclosure of which is incorporated by reference herein. For instance, such a form of packaging (350) may facilitate sterilization and sealing of medical device (310) separate from sterilization and sealing of batteries (320) and control module (330). Various other suitable ways in which packaging (350) may be configured will be apparent to those of ordinary skill in the art in view of the teachings herein.


Medical device (310) of the present example includes a handpiece (312), an end effector (314) disposed at the distal end of a shaft (316), and a trigger (318). As shown in FIG. 7, handpiece (312) includes a first slot (360) configured to receive battery (320) and a second slot (370) configured to receive control module (330). Such slots (360, 370) may include latching features configured to selectively retain battery (320) and control module (330) in handpiece (312) after insertion. Slots (360, 370) may also include leads sufficient to establish electrical communication with inserted battery (320) and control module (330). By way of example only, either slot (360, 370) may be configured in accordance with the teachings of U.S. patent application Ser. No. 13/151,512, entitled “Medical Device with Feature for Sterile Acceptance of Non-Sterile Reusable Component,” filed Jun. 2, 2011, issued as U.S. Pat. No. 9,072,523 on Jul. 7, 2015, the disclosure of which is incorporated by reference herein. Other suitable configurations for slots (360, 370) will be apparent to those of ordinary skill in the art in view of the teachings herein. In some versions, a charged battery (320) is preloaded in handpiece (312), such that medical device (310) is immediately ready for use upon removal from packaging (350). In some such instances, remaining batteries (320) in packaging (350) are simply relied on for backup in the event that the preloaded battery (320) loses sufficient charge.


Once coupled with handpiece (312), battery (320) and control module (330) cooperate to selectively activate end effector (314) in accordance with actuations of trigger (318). As also shown in FIG. 7, handpiece (312) of the present example also includes a battery life indicator (362), which is operable to indicate how much charge is left in battery (320). As with other components described herein, battery life indicator (362) is merely optional. If the charge level of a battery (320) gets too low during a medical procedure, the user may simply eject battery (320) as described below and use another, fully charged battery (320) from packaging (350). In some instances, having several batteries (320) on hand in packaging (350) may facilitate use of relatively small batteries (320), which may in turn reduce the overall weight of medical device (310) during use of medical device (310) in a medical procedure. Extra batteries (320) may continue to be charged in packaging (350) during the medical procedure.


By way of example only, end effector (314) may comprise a harmonic blade, a pair of clamping jaws, and/or one or more electrosurgical elements. It should be understood that medical device (310) may be constructed and operable in accordance with medical device (10, 100) and/or in accordance with at least some of the teachings of any of the references cited herein. Various other kinds of devices to which the teachings of medical device (310) may be applied will be apparent to those of ordinary skill in the art in view of the teachings herein.


As best seen in FIG. 6, kit (300) also includes a power cord (322) coupled with batteries (320). In the present example, power cord (322) is coupled with batteries (320) via a charger (324) that is integral with packaging (350) (e.g., disposed within a recess formed by packaging (350), etc.). When plugged into a conventional wall outlet (326) (or some other power source), power cord (322) is operable to charge batteries (320). In some versions, kit (300) is shipped and stored with batteries (320) having only a partial charge, such that batteries (320) need to be charged before medical device (310) is used in a medical procedure. In other words, in an exemplary use, a user may initially receive kit (300) in the form shown in FIG. 5, which may include a peelable film cover, lid, or other removable feature. Right before medical device (310) is to be used in a medical procedure, the user may place kit (300) on a mayo stand in the operating room (or place kit (300) elsewhere), remove the film cover, lid, or other removable feature, and then plug power cord (322) into wall outlet (326) as shown in FIG. 6. Charger (324), packaging (350), and/or batteries (320) may include visual and/or audio indicators configured to convey the charge state of batteries (320) to the user. Once batteries (320) are sufficiently charged, the user may then insert battery (320) and control module (330) into respective slots (360, 370) of handpiece (312), as shown in FIG. 7. Medical device (310) is then ready to be used in a medical procedure.


Handpiece (312) of the present example also includes a component ejection feature (380), which includes a button and a spring-loaded release mechanism. As shown in FIG. 8, component ejection feature (380) is operable to eject control module (330) and battery (320) from handpiece (312). In some versions, a single component ejection feature (380) simultaneously ejects both battery (320) and control module (330). In some other versions, separate component ejection features (380) are provided for independent ejection of battery (320) and control module (330). It should be understood that it may be desirable in some instances to eject battery (320) and/or control module (330) from medical device (310), such as after the medical procedure is complete. For instance, it may be desirable in some instances to dispose of battery (320) and/or control module (330) separate from disposal of other components of medical device (310), such as to avoid environmental concerns.


As another merely illustrative example, it may be desirable in some instances to separately collect batteries (320) and/or control module (330) for reclamation (e.g., cleaning and re-sterilization, etc.) and re-use. For instance, this may be desirable where battery (320) and/or control module (330) are relatively high cost items; and/or to again avoid environmental concerns that might be associated with simple disposal of battery (320) and/or control module (330). As shown in FIG. 9, reclamation bag (340) may be used to collect used batteries (320), control module (330), and/or other components (e.g., charger (324), etc.). Filled reclamation bag (340) may then be sent off to reclaim, salvage, or otherwise further process the components contained therein, with the remainder of kit (300) being discarded or otherwise disposed of. In the present example, reclamation bag (340) includes a drawstring (342), though it should be understood that any other suitable type of closure feature may be used.


In some versions, control module (330) is not removable from medical device (310), such that only battery (320) is removable from medical device (310). Similarly, in some versions control module (330) is removable from medical device (310) and either battery (320) is non-removable or medical device (310) receives power from some other source. It should also be understood that charger (324) or some other feature of kit (300) may be configured to safely discharge batteries (320) before batteries (320) are disposed of or sent off for reclamation/processing in reclamation bag (340). Still other suitable components, features, configurations, and operabilities of kit (300) will be apparent to those of ordinary skill in the art in view of the teachings herein.


IV. Exemplary Medical Device Conductive Charging Stations

As noted above, in medical devices having internal power sources such as batteries, etc., it may be necessary to charge or recharge such internal power sources before and/or during use of the medical device in a medical procedure. In some instances, this may require physically coupling (e.g., via contact) a component of the medical device with a component of a docking station or other type of charging device. In some settings, such physical contact may present concerns as to sterility. In particular, such as situations where the docking station or other charging device is re-used, it may be desirable in some instances to provide ready re-use of such a docking station or other charging device without necessarily having to fully re-sterilize the docking station or other charging device between uses. Thus, in some situations where the docking station or other charging device is not sterile, it may be desirable to prevent such non-sterility from contaminating a sterile medical device when some degree of contact is required between the docking station or other charging device and the medical device in order to charge/recharge the medical device. The following examples present ways in which a non-sterile charging device may be used to charge a sterile medical device without compromising the sterility of the medical device despite some degree of contact with the medical device. Further examples and variations will be apparent to those of ordinary skill in the art in view of the teachings herein.


A. Exemplary Charging Station with Sterile Barrier



FIGS. 10-12 show an exemplary charging station (400) that includes a base (410), a film (420), and a collar (430). Charging station (400) is shown as coupling with a handpiece (450) of a medical device. As shown in FIG. 12, handpiece (450) includes an integral power source (460) and a pair of contacts (462) that are coupled with power source (460) via wires (464). Power source (460) may comprise one or more batteries and/or various other components. Contacts (462) are recessed within handpiece (450) in this example. In some versions, contacts (462) define or are provided in respective sockets. It should be understood that the medical device having handpiece (450) may be constructed and operable in accordance with medical device (10, 100) and/or in accordance with at least some of the teachings of any of the references cited herein. Various other types of devices that may include handpiece (450) will be apparent to those of ordinary skill in the art in view of the teachings herein.


Base (410) includes a power cord (412) that is configured to plug into a conventional wall outlet or a piece of capital equipment. A pair of spike contacts (414) protrude upwardly from base (410). While spike contacts (414) have a sharp conical shape in the present example, it should be understood that contacts (414) may have any other suitable shape. Contacts (462) of handpiece (450) are configured to receive spike contacts (414) when handpiece is coupled with charging station (400), such that spike contacts (414) are operable to charge power source (460). Collar (430) is configured to insertingly receive a lower portion of handpiece (450) and is configured to provide structural support to handpiece (450). In particular, collar (430) has angled sidewalls (432) providing a tapered configuration, which helps prevent handpiece (450) and collar (430) from tipping over. While contacts (414) are shown protruding upwardly from base (410), it should be understood that the contacts (414) could alternatively reside and point downwardly from within handpiece (450) and make contact with contacts of base (410).


Film (420) comprises a sterile sheet of plastic film, and is configured to provide a sterile barrier between the exterior of sterile handpiece (450) and non-sterile base (410). In particular, film (420) is interposed between handpiece (450) and base (410). In the present example, collar (430) is also sterile, and is also positioned above film (420). It should be understood, however, that film (420) may optionally be draped over collar (430), and that film (420) may deform when handpiece (450) is inserted in collar (430), such that film (420) may serve as a sterile barrier between the sterile exterior of handpiece (450) and a non-sterile collar (430). As best seen in FIG. 10, film (420) of the present example includes a pair of openings (422) associated with spike contacts (414). In particular, openings (422) are sized and configured to permit passage of spike contacts (414) therethrough. In some other versions, openings (422) are eliminated, and spike contacts (414) pierce and poke through film (420) when handpiece (450) is pressed onto base (410) through collar (430).


In some versions, spike contacts (414) are selectively retractable within base (410). For instance, spike contacts (414) may be retracted in base (410) as charging station (400) is being prepared for use, as shown in FIG. 10. Base (410) may include an actuating mechanism (not shown) that is operable to deploy spike contacts (414) at an appropriate time. Such a mechanism may employ springs, solenoids, and/or various other types of components to deploy spike contacts (414). By way of example only, base (410) may include a button, switch, slider, or other feature operable to selectively activate such an actuation mechanism. As another merely illustrative example, base (410) may include a feature that is responsive to placement of collar (430) and/or handpiece (450) against base (410), such that spike contacts (414) deploy upon placement of collar (430) and/or handpiece (450) against base (410).


In some other versions, spike contacts (414) are integral features of collar (430) instead of being integral features of base (410). For instance, base (410) may present a pair of contacts that mate with complementary contacts on the underside of collar (430), through openings (422) in film (420). Such contacts on the underside of collar (430) may be in communication with spike contacts (414). Still other suitable components, features, configurations, and operabilities of charging station (400) will be apparent to those of ordinary skill in the art in view of the teachings herein.


B. Exemplary Charging Station with Breakaway Prongs



FIGS. 13A-13C show another exemplary charging station (500) that includes a base (510) having a recess (512) and movable retention pins (514). Recess (512) is sized and shaped to receive a lower portion of a handpiece (550) of a medical device. Handpiece (550) of this example includes an integral power source (560) and a pair of protruding prongs (562) that are removably received in sockets (564) of handpiece (550). For instance, sockets (564) may include conductive leaf spring features and/or other features that substantially hold prongs (562) in sockets (564) yet release prongs (562) from sockets (564) when prongs (562) are pulled from sockets (564) with sufficient force. Sockets (564) are further coupled with power source (560) via wires (566). Power source (560) may comprise one or more batteries and/or various other components. It should be understood that the medical device having handpiece (550) may be constructed and operable in accordance with medical device (10, 100) and/or in accordance with at least some of the teachings of any of the references cited herein. Various other types of devices that may include handpiece (550) will be apparent to those of ordinary skill in the art in view of the teachings herein.


Base (510) of the present example includes a cable (not shown) that is configured to plug into a conventional wall outlet or piece of capital equipment, etc., to deliver a charge to power source (560) as described in greater detail below. Retention pins (514) are configured to move toward a central member (516) within recess (512) when prongs (562) are sufficiently positioned within recess (512). By way of example only, base (510) may include a spring-loaded trip mechanism that is responsive to insertion of prongs (562) in recess, and such a trip mechanism may cause pins (514) to move toward central member (516) as shown in FIG. 13B. Such a trip mechanism may include one or more springs or other resilient members, levers, rockers, cams, etc. As can be seen in FIGS. 13B-13C, pins (514) are configured to trap prongs (562), such as by passing through corresponding openings (not shown) formed in prongs (562). In addition, pins (514) are conductive and are configured to deliver a charge to prongs (562) to thereby charge power source (560). It should therefore be understood that, in some versions, central member (516) is made of a non-conductive material, such that pins (514) will not short out when they both contact central member (516).


As can also be seen in FIG. 13B, the relative lengths of prongs (562) and recess (512) are selected such that handpiece (550) does not have to contact base (510) during charging. In particular, a gap (520) is presented between base (510) and handpiece (550). Thus, in the present example, charging station (500) may be non-sterilized and yet still not contaminate sterile handpiece (550) during charging of power source (560). In some other versions, the interior of recess (512) and at least a top portion of base (510) are sterilized to further avoid the risk of inadvertently contaminating sterile handpiece (550). It should also be understood that prongs (562) and recess (512) may have any other suitable relative lengths, such that gap (520) is eliminated and such that part of handpiece (550) is also disposed in recess (512) during charging of power source (560).


In an exemplary use, a user initially positions handpiece (550) over base (510) as shown in FIG. 13A. The user then urges handpiece (550) downwardly, such that prongs (562) are disposed in recess, and such that pins (514) move toward central member (516) to capture and contact prongs (562) as shown in FIG. 13B. Handpiece (550) remains in this position during charging of power source (560). The charge level of power source (560) may be monitored by a charge indicator on handpiece (550), on base (510), or elsewhere. Once power source (560) is sufficiently charged, handpiece (550) is pulled upwardly, leaving prongs (562) in base (510) as shown in FIG. 13C. In some versions, base (510) is weighted or otherwise secured to the surface on which it rests in order to provide sufficient resistance to friction encountered by prongs (562) in sockets (564), such that base (510) is not lifted away with handpiece (550) by prongs (562).


In some versions, handpiece (550) includes a door, cap, or other feature that is operable to close off sockets (564) when prongs (562) are pulled free from sockets (564), thereby effectively sealing off the bottom of handpiece (550). Such a feature may be manually operated after handpiece (550) is pulled away from base (510). Alternatively, a mechanism may automatically case such a feature to be released to close off sockets (564) when prongs (562) are pulled free from sockets (564). Various suitable ways in which such a feature may be provided will be apparent to those of ordinary skill in the art in view of the teachings herein. Similarly, various other suitable components, features, configurations, and operabilities of charging station (500) and handpiece (550) will be apparent to those of ordinary skill in the art in view of the teachings herein.


V. Exemplary Medical Device Inductive Charging Stations

The examples described above with reference to FIGS. 10-13C relate to conductive charging, where charging of a power source is provided through direct contact between conductive materials. An alternative form of charging includes the use of inductive coupling. In particular, energy is exchanged from one inductive coil to another inductive coil via an electromagnetic field, such that the coils together form a transformer, without the coils coming into physical contact with each other. In the context of medical devices, inductive charging may still present concerns as to sterility, though such concerns may be addressed differently in the context of inductive charging than they would be addressed in the context of conductive charging. As described in greater detail below, a non-sterile inductive charging station may be used to charge a power source in a sterile medical device without compromising the sterility of the medical device. While several such examples will be discussed in greater detail below, other examples and variations will be apparent to those of ordinary skill in the art in view of the teachings herein.


A. Exemplary Charging Pad with Wireless Communication of Charge State



FIGS. 14-16 depict examples of inductive charging pads that may be used to provide inductive charging and wireless communication of charge state. In particular, FIG. 14 schematically depicts a charging pad (600) and a medical device (650). Charging pad (600) of this example includes a primary inductive coil (602), a control module (604), a charge indicator (606), and a power cable (608). Power cable (608) is configured to plug into a conventional wall outlet or piece of capital equipment, etc., and thereby provide power to inductive coil (602). In addition to regulating the power transmitted via inductive coil (602), control module (604) is configured to superimpose data on the waveform transmitted by inductive coil (602), and is further configured to process data received by inductive coil (602), as will be described in greater detail below. In other words, control module (604) is configured to provide bi-directional data communication through inductive coil (602).


Medical device (650) of this example includes an integral power source (660), which includes a secondary inductive coil (662), a control module (664), and at least one battery (666). As with other control modules referred to herein, control module (664) may include a variety of components, including but not limited to a printed circuit board, a microprocessor, a memory device, etc. Various suitable components, features, and configurations for the various control modules referred to herein will be apparent to those of ordinary skill in the art in view of the teachings herein. Medical device (650) also includes a charge indicator (656) in this example, though it should be understood that in other versions either or both of charge indicators (606, 656) may be omitted. It should also be understood that medical device (650) may be constructed and operable in accordance with medical device (10, 100) and/or in accordance with at least some of the teachings of any of the references cited herein. For instance, medical device (650) may include an ultrasonic or electrosurgical end effector (not shown) that is selectively activated by power source (660). Various other types of forms that medical device (650) may take will be apparent to those of ordinary skill in the art in view of the teachings herein.


With power cable (608) plugged in, and when medical device (650) is brought within sufficient proximity of charging pad (600), coils (602, 662) inductively couple, thereby forming a transformer and allowing the wireless transfer of energy from coil (602) to coil (662), thereby charging battery (666) through induction of a current in coil (662). Control module (664) is operable to monitor the charge level of battery (666) in real time. Control module (664) is further operable to drive charge indicator (656) to indicate the charge level of battery (666) (e.g., visually and/or audibly) in real time. In addition, control module (664) is operable to communicate the charge level of battery (666) back to control module (664) via coils (662, 602). For instance, control module (664) may superimpose a data carrier on the charging waveform through modulation, allowing such data to be communicated form coil (662) to coil (602). Control module (604) may receive such data via coil (602) and react to it in various ways. For instance, control module (604) may drive charge indicator (606) to indicate the charge level of battery (666) (e.g., visually and/or audibly) in real time. In addition, control module (604) may adjust the charging current provided through coils (602, 662), based at least in part on the charge level of battery (666). Control modules (604, 664) may thus together provide a feedback loop, allowing the charging profile of battery (666) (e.g., frequency and/or other parameters) to be optimized in real time for whichever battery (666) is coupled with charging pad (600). Various suitable ways in which such communication between control modules (602, 664) and corresponding real time adjustments may be provided will be apparent to those of ordinary skill in the art in view of the teachings herein.


In some versions, the electronics in charging pad (600) may be encapsulated in a potting compound and/or be otherwise encapsulated. Such encapsulation may enable charging pad (600) to be sterilized using steam and/or other sterilization techniques that might otherwise not be available without damaging charging pad (600). Of course, charging pad (600) may be sterilized using a variety of other techniques, including but not limited to electron beam sterilization.


In some settings, it may be desirable to maximize the interface area of an inductive charging pad to maximize the amount of current that may be transferred to a battery pack or other type of power source. To that end, FIG. 15 shows an exemplary charging pad (670) that includes a power cord (672) and a relatively large primary coil (674). Primary coil (674) has a diameter spanning across almost the entire length and width of charging pad (670). Primary coil (674) may inductively couple with a similarly sized secondary coil in a medical device (not shown) to provide optimized inductive charging to a battery within the medical device. FIG. 16 shows an exemplary charging pad (680) that includes a power cord (682) and a plurality of smaller primary coils (684). While primary coils (684) are relatively small in this example, they are provided in an array that spans across almost the entire length and width of charging pad (690). Primary coils (684) may inductively couple with similarly sized and arranged secondary coils in a medical device (not shown) to provide optimized inductive charging to a battery or batteries within the medical device. It should also be understood that charging pad (690) may accommodate various different medical devices having inductive charging interfaces of various sizes (e.g., such that not all primary coils (684) are necessarily used every time). Still other suitable components, features, configurations, and operabilities of charging pad (600, 670, 680) and medical device (650) will be apparent to those of ordinary skill in the art in view of the teachings herein. It should also be understood that any charging pad or charging device referred herein may include the communication capabilities discussed above with respect to charging pad (600), if desired.


B. Exemplary Charging Pad on Stand with Sterile Drape


As noted above, an inductive charging pad may be sterilized using steam, electron beam sterilization, and/or using other sterilization techniques. It should also be understood, however, that an inductive charging pad may still be used, even in an operating room, without the charging pad necessarily being sterilized, and without the non-sterile charging pad compromising the sterility of the medical device that it charges. For instance, as shown in FIG. 17, an inductive charging pad (800) may be placed on a mayo stand (802) (or elsewhere) in an operating room, and a sterile drape (804) may be placed over charging pad (800) to act as a sterile barrier. Thus, during an operation, and with charging pad (800) plugged into a conventional wall outlet (806) via a cable (808), sterile battery packs (not shown) that are capable of being inductively charged may simply be placed directly on sterile drape (804) over charging pad (800). For instance, such battery packs may have integral inductive charging coils that establish communication with one or more complementary coils in charging pad (800). Such battery packs may thus be charged by charging pad (800) through sterile drape (804), and sterile drape (804) may help maintain the sterility of the battery packs by preventing contamination from non-sterile charging pad (800). Sterile drape (804) may comprise any suitable material and construction, including but not limited to a plastic film, a suitable fabric, etc.


C. Exemplary Charging Peg on Stand with Sterile Drape



FIGS. 18-19 depict another exemplary use of a sterile drape and inductive charging device. In particular, FIGS. 18-19 show an inductive charging device (900) on a mayo stand (930), with a sterile drape (940) laid over inductive charging device (900). Inductive charging device (900) of this example includes a cable (902) that is configured to plug into a conventional wall outlet (904), a base portion (906), an upright peg portion (908), and a primary coil (910). Primary coil (910) is shown in FIG. 19 as being located within upright peg portion (908), though it should be understood that primary coil (910) may be located elsewhere. For instance, in some other versions, primary coil (910) is located in base portion (906) (e.g., coaxial with upright peg portion (908), etc.).


Charging device (900) of this example is configured for use with a medical device having a handpiece (950) as shown in FIG. 19. In particular, handpiece (950) includes a secondary coil (952), which is in communication with an integral power source (954) in handpiece (950). The bottom of handpiece (950) defines a recess (956) that is configured to receive upright peg portion (908) of charging device (900). Upright peg portion (908) and recess (956) thus cooperate to assist in properly positioning coils (910, 952) relative to each other. Upright peg portion (908) also provides some degree of structural support to handpiece (950) (e.g., reducing the likelihood of handpiece (950) tipping over, etc.). When coils (910, 952) are properly positioned within sufficient proximity of each other, coils (910, 952) inductively couple, forming a transformer and charging power source (954). Sterile drape (940) conforms to the interface between handpiece (950) and charging device (900), this maintaining the sterile barrier between these components while also permitting inductive charging to occur therethrough.


As with charging pad (800), charging device (950) may be used in an operating room without being sterile and without compromising the sterility of handpiece (950) or other items in the operating room. In other words, even if charging device (900) is non-sterile, power source (954) may be charged by charging device (900) through sterile drape (940), and sterile drape (940) may help maintain the sterility of handpiece (950) by preventing contamination from non-sterile charging device (900). The medical device having handpiece (950) may be constructed and operable in accordance with medical device (10, 100) and/or in accordance with at least some of the teachings of any of the references cited herein. Various other types of devices that may include handpiece (950) will be apparent to those of ordinary skill in the art in view of the teachings herein. Similarly, various other suitable forms that charging device (900) may take will be apparent to those of ordinary skill in the art in view of the teachings herein.


VI. Exemplary Medical Device Powered by Supercapacitor

While several of the examples described above have included batteries as a primary integral source of power in a medical device, it should be understood that other types of components may provide a primary integral source of power in a medical device. For instance, FIG. 20 shows a medical device (1000) having an integral power source (1010) that comprises one or more supercapacitors, also known as electric double-layer capacitors (EDLCs). Medical device may otherwise be constructed and operable in accordance with medical device (10, 100) and/or in accordance with at least some of the teachings of any of the references cited herein. It should be understood that one or more supercapacitors of power source (1010) may provide sufficient power to perform one or more operational acts with medical device (1000) (e.g., one or more transections with an end effector of medical device (1000), etc.). However, the power provided by supercapacitors of power source (1010) may be more in the form of short bursts as compared to the power delivery that might be expected from conventional batteries. It therefore might be warranted in some instances to provide relatively immediate recharging of power source (1010).



FIG. 20 also shows a charging pad (1020) draped directly over the torso of a patient (1030). Charging pad (1020) includes a power cable (1022) that is configured to plug into a conventional wall outlet or piece of capital equipment, etc. Charging pad (1020) is further configured to charge power source (1010) through inductive coupling or otherwise. Due to the nature of supercapacitors, the charging of power source (1010) may be much faster than the charge time that might otherwise be expected with conventional rechargeable batteries. Thus, in the present example, a surgeon may repeatedly place medical device (1000) on or at least directly over charging pad (1020) as many times as needed to keep power source (1010) sufficiently charged during a medical procedure. Charging pad (1020) may be sterilized before use; or may have a sterile drape placed over it (and under it) to avoid contaminating medical device (1000) (and patient (1030)). It should also be understood that charging pad (1020) may be placed anywhere, and need not necessarily be draped over patient (1030). It should also be understood that medical device (1000) may include a magnet or other feature that helps keep medical device (1000) upright (e.g., to avoid tipping over, etc.) when medical device (1000) is plaled on charging pad (1020). Various other suitable ways in which supercapacitors may be incorporated into a medical device will be apparent to those of ordinary skill in the art in view of the teachings herein. It should also be understood that, in any example mentioned herein that includes one or more batteries, such batteries may be replaced or supplemented with a capacitor, supercapacitor, and/or other type of power source.


VII. Conclusion

It should be appreciated that any patent, publication, or other disclosure material, in whole or in part, that is said to be incorporated by reference herein is incorporated herein only to the extent that the incorporated material does not conflict with existing definitions, statements, or other disclosure material set forth in this disclosure. As such, and to the extent necessary, the disclosure as explicitly set forth herein supersedes any conflicting material incorporated herein by reference. Any material, or portion thereof, that is said to be incorporated by reference herein, but which conflicts with existing definitions, statements, or other disclosure material set forth herein will only be incorporated to the extent that no conflict arises between that incorporated material and the existing disclosure material.


Embodiments of the present invention have application in conventional endoscopic and open surgical instrumentation as well as application in robotic-assisted surgery.


Embodiments of the devices disclosed herein can be designed to be disposed of after a single use, or they can be designed to be used multiple times. Embodiments may, in either or both cases, be reconditioned for reuse after at least one use. Reconditioning may include any combination of the steps of disassembly of the device, followed by cleaning or replacement of particular pieces, and subsequent reassembly. In particular, embodiments of the device may be disassembled, and any number of the particular pieces or parts of the device may be selectively replaced or removed in any combination. Upon cleaning and/or replacement of particular parts, embodiments of the device may be reassembled for subsequent use either at a reconditioning facility, or by a surgical team immediately prior to a surgical procedure. Those skilled in the art will appreciate that reconditioning of a device may utilize a variety of techniques for disassembly, cleaning/replacement, and reassembly. Use of such techniques, and the resulting reconditioned device, are all within the scope of the present application.


By way of example only, embodiments described herein may be processed before surgery. First, a new or used instrument may be obtained and if necessary cleaned. The instrument may then be sterilized. In one sterilization technique, the instrument is placed in a closed and sealed container, such as a plastic or TYVEK bag. The container and instrument may then be placed in a field of radiation that can penetrate the container, such as gamma radiation, x-rays, or high-energy electrons. The radiation may kill bacteria on the instrument and in the container. The sterilized instrument may then be stored in the sterile container. The sealed container may keep the instrument sterile until it is opened in a medical facility. A device may also be sterilized using any other technique known in the art, including but not limited to beta or gamma radiation, ethylene oxide, or steam.


Having shown and described various embodiments of the present invention, further adaptations of the methods and systems described herein may be accomplished by appropriate modifications by one of ordinary skill in the art without departing from the scope of the present invention. Several of such potential modifications have been mentioned, and others will be apparent to those skilled in the art. For instance, the examples, embodiments, geometrics, materials, dimensions, ratios, steps, and the like discussed above are illustrative and are not required. Accordingly, the scope of the present invention should be considered in terms of the following claims and is understood not to be limited to the details of structure and operation shown and described in the specification and drawings.

Claims
  • 1. A medical system, comprising: (a) a medical device, including: (i) a housing,(ii) an integral power source positioned within the housing,(iii) an active element in communication with the integral power source, wherein the active element is operable to perform an operation on a tissue of a patient,(iv) a recess, and(v) a first charging feature positioned within the housing in communication with the integral power source;(b) a charging device including a second charging feature, wherein the charging device is configured to communicate with the integral power source of the medical device to thereby charge the integral power source of the medical device when the first charging feature is aligned with the second charging feature, wherein the charging device further includes a base portion and a peg portion extending upwardly from the base portion, wherein the recess of the medical device is configured to receive the peg portion of the charging device such that the peg portion supports the medical device thereon in a predetermined alignment thereby reducing the likelihood of the medical device moving relative to the charging device for supporting the medical device in the predetermined alignment while charging the integral power source of the medical device; and(c) a sterile barrier having a flexible portion interposed between the first charging feature within the housing and the second charging feature of the charging device, wherein the sterile barrier is configured to permit the second charging feature of the charging device to establish contact with the first charging feature of the medical device without compromising sterility of exterior portions of the medical device.
  • 2. The medical system of claim 1, wherein the first charging feature of the medical device includes a first coil, wherein the second charging feature of the charging device includes a second coil, wherein the first and second coils are configured to establish an inductive coupling to charge the integral power source.
  • 3. The medical system of claim 1, wherein the first charging feature of the medical device includes a first coil positioned about the recess, wherein the second charging feature of the charging device includes a second coil positioned within the peg portion, wherein the first and second coils are configured to establish an inductive coupling to charge the integral power source when the peg portion is received within the recess.
  • 4. The medical system of claim 1, wherein the sterile barrier includes a flexible drape configured to conform to the interface between the medical device and the charging device.
  • 5. The medical system of claim 1, wherein the integral power source includes a battery.
  • 6. The medical system of claim 1, wherein the integral power source includes a supercapacitor.
  • 7. The medical system of claim 1, wherein the active element includes an ultrasonic blade or an RF electrode.
  • 8. The medical system of claim 1, wherein the charging device includes a cable configured to be plugged into an electrical outlet to supply power to the second charging feature.
  • 9. The medical system of claim 1, wherein the medical device further includes a control module in communication with the first charging feature, wherein the charging device further includes a control module in communication with the second charging feature, wherein the control modules are configured to provide data communication along a waveform communicated between the first charging feature and the second charging feature.
  • 10. The medical system of claim 9, wherein the waveform further communicates power from the second charging feature to the first charging feature such that the data communication is superimposed on the power communication.
  • 11. The medical system of claim 1, wherein the second charging feature is within the peg portion of the charging device, and wherein the flexible portion is interposed between the first charging feature within the housing and the peg portion of the charging device.
  • 12. A medical system, comprising: (a) a charging device including a primary coil;(b) a medical device, including: (i) a housing,(ii) an integral power source positioned within the housing,(iii) an active element in communication with the integral power source, wherein the active element is operable to perform an operation on a tissue of a patient, and(iv) a secondary coil positioned within the housing in communication with the integral power source; and(c) a sterile barrier interposed between the housing and the charging device, wherein the sterile barrier includes a flexible drape interposed between secondary coil within the housing and the primary coil of the charging device and configured to conform to the interface between the medical device and the charging device;wherein the primary and secondary coils are configured to establish an inductive coupling to charge the integral power source;wherein the charging device is configured to receive the medical device such that the primary coil receives the secondary coil therein for aligning primary and secondary coils in a predetermined alignment and supporting medical device while charging the integral power source; andwherein the sterile barrier is configured to permit the primary coil of the charging device to establish contact with the secondary coil of the medical device without compromising sterility of exterior portions of the medical device.
  • 13. The medical system of claim 12, wherein the primary coil of the charging device is positioned within a peg portion of the charging device, wherein the secondary coil of the medical device is positioned about a recess of the housing, wherein the peg portion is configured to be received within the recess to establish the inductive coupling.
  • 14. The medical system of claim 13, wherein the peg portion is configured to support the medical device when the peg portion is received within the recess to thereby reduce the likelihood of the medical device moving relative to the charging device.
  • 15. The medical system of claim 12, wherein the sterile barrier includes a flexible drape configured to conform to the interface between the medical device and the charging device.
  • 16. The medical system of claim 12, wherein the active element includes an ultrasonic blade or an RF electrode.
  • 17. The medical system of claim 12, wherein the primary coil defines a primary axis such that the primary coil surrounds the primary axis, wherein the secondary coil defines a secondary axis such that the secondary coil surrounds the secondary axis, and wherein the charging device is configured to receive the medical device such that the primary axis coaxially aligns with the secondary axis in the predetermined alignment.
  • 18. A medical system, comprising: (a) a medical device, including: (i) a housing,(ii) an integral power source positioned within the housing, wherein the integral power source includes a supercapacitor,(iii) an active element in communication with the integral power source, wherein the active element is operable to perform an operation on a tissue of a patient, and(iv) a first charging feature defining a first axis and positioned within the housing in communication with the integral power source;(b) a charging device including a second charging feature defining a second axis, wherein the charging device is configured to communicate with the integral power source of the medical device to thereby charge the integral power source of the medical device when the first axis of the first charging feature is coaxially aligned with second axis of the second charging feature in a predetermined alignment; and(c) a sterile barrier interposed between the housing and the charging device, wherein the sterile barrier is configured to permit the second charging feature of the charging device to establish contact with the first charging feature of the medical device without compromising sterility of exterior portions of the medical device, wherein the sterile barrier includes a flexible drape interposed between the first charging feature within the housing and the second charging feature of the charging device and configured to conform to the interface between the medical device and the charging device.
  • 19. The medical system of claim 18, wherein the active element includes an ultrasonic blade or an RF electrode.
  • 20. The medical system of claim 18, wherein the first axis extends along the second axis in the predetermined alignment.
PRIORITY

This application is a continuation of U.S. patent application Ser. No. 15/212,423, entitled “Sterile Medical Instrument Charging Device,” filed on Jul. 18, 2016, published as U.S. Pub. No. 2016/0329614 on Nov. 10, 2016, issued as U.S. Pat. No. 10,660,695 on May 26, 2020, which is a continuation of U.S. patent application Ser. No. 13/151,503, entitled “Sterile Medical Instrument Charging Device,” filed on Jun. 2, 2011, issued as U.S. Pat. No. 9,597,143 on Mar. 21, 2017. U.S. patent application Ser. No. 13/151,503, filed on Jul. 2, 2011, issued as U.S. Pat. No. 9,597,143 on Mar. 21, 2017, claims priority to U.S. Provisional Application Ser. No. 61/410,603, filed Nov. 5, 2010, entitled “Energy-Based Surgical Instruments,” the disclosure of which is incorporated by reference herein. U.S. patent application Ser. No. 13/151,503, Jul. 2, 2011, issued as U.S. Pat. No. 9,597,143 on Mar. 21, 2017, also claims priority to U.S. Provisional Application Ser. No. 61/487,846, filed May 19, 2011, entitled “Energy-Based Surgical Instruments,” the disclosure of which is incorporated by reference herein.

US Referenced Citations (410)
Number Name Date Kind
1754806 Stevenson Apr 1930 A
3297192 Swett Jan 1967 A
3419198 Pettersen Dec 1968 A
3619671 Shoh Nov 1971 A
4034762 Cosens et al. Jul 1977 A
4057220 Kudlacek Nov 1977 A
4535773 Yoon Aug 1985 A
4641076 Linden et al. Feb 1987 A
4641077 Pascaloff Feb 1987 A
4662068 Polonsky May 1987 A
4666037 Weissman May 1987 A
4685459 Koch et al. Aug 1987 A
4717018 Sacherer et al. Jan 1988 A
4717050 Wright Jan 1988 A
4721097 D'Amelio Jan 1988 A
4768969 Bauer et al. Sep 1988 A
4800878 Cartmell Jan 1989 A
4844259 Glowczewskie, Jr. et al. Jul 1989 A
4878493 Pasternak et al. Nov 1989 A
5071417 Sinofsky Dec 1991 A
5107155 Yamaguchi Apr 1992 A
5144771 Miwa Sep 1992 A
5169733 Savovic et al. Dec 1992 A
5176677 Wuchinich Jan 1993 A
5246109 Markle et al. Sep 1993 A
5273177 Campbell Dec 1993 A
5277694 Leysieffer et al. Jan 1994 A
5308358 Bond et al. May 1994 A
5322055 Davison et al. Jun 1994 A
5339799 Kami et al. Aug 1994 A
5357732 Markle et al. Oct 1994 A
5358508 Cobb et al. Oct 1994 A
5361902 Abidin et al. Nov 1994 A
5429229 Chester et al. Jul 1995 A
5449370 Vaitekunas Sep 1995 A
5452391 Chou et al. Sep 1995 A
5454378 Palmer et al. Oct 1995 A
5501607 Yoshioka et al. Mar 1996 A
5507297 Slater et al. Apr 1996 A
5561881 Klinger et al. Oct 1996 A
5578052 Koros et al. Nov 1996 A
5580258 Wakata Dec 1996 A
5582617 Klieman et al. Dec 1996 A
5590778 Dutchik Jan 1997 A
5592065 Oglesbee et al. Jan 1997 A
5597371 Liberti et al. Jan 1997 A
5599350 Schulze et al. Feb 1997 A
5630420 Vaitekunas May 1997 A
5630456 Hugo et al. May 1997 A
5690222 Peters Nov 1997 A
5707369 Vaitekunas et al. Jan 1998 A
5741305 Vincent et al. Apr 1998 A
5776155 Beaupre et al. Jul 1998 A
5800336 Ball et al. Sep 1998 A
5817128 Storz Oct 1998 A
5868244 Ivanov et al. Feb 1999 A
5873873 Smith et al. Feb 1999 A
5882310 Marian, Jr. Mar 1999 A
5893835 Witt et al. Apr 1999 A
5935144 Estabrook Aug 1999 A
5938633 Beaupre Aug 1999 A
5944737 Tsonton et al. Aug 1999 A
5951575 Bolduc et al. Sep 1999 A
5980510 Tsonton et al. Nov 1999 A
5997531 Loeb et al. Dec 1999 A
6018227 Kumar et al. Jan 2000 A
6051010 Dimatteo et al. Apr 2000 A
6056735 Okada et al. May 2000 A
6063098 Houser et al. May 2000 A
6066151 Miyawaki et al. May 2000 A
6083191 Rose Jul 2000 A
6083223 Baker Jul 2000 A
6099537 Sugai et al. Aug 2000 A
6113593 Tu et al. Sep 2000 A
6113596 Hooven et al. Sep 2000 A
6123702 Swanson et al. Sep 2000 A
6165191 Shibata et al. Dec 2000 A
6190386 Rydell Feb 2001 B1
6204592 Hur Mar 2001 B1
6214023 Whipple et al. Apr 2001 B1
6246896 Dumoulin et al. Jun 2001 B1
6248238 Burtin et al. Jun 2001 B1
6287304 Eggers et al. Sep 2001 B1
6325811 Messerly Dec 2001 B1
6339368 Leith Jan 2002 B1
6398755 Belef et al. Jun 2002 B1
6409742 Fulton, III et al. Jun 2002 B1
6500176 Truckai et al. Dec 2002 B1
6500188 Harper et al. Dec 2002 B2
6512667 Shiue et al. Jan 2003 B2
6514267 Jewett Feb 2003 B2
6517561 Phillips Feb 2003 B1
6520185 Bommannan et al. Feb 2003 B1
6561983 Cronin et al. May 2003 B2
6562032 Ellman et al. May 2003 B1
6609414 Mayer et al. Aug 2003 B2
6622731 Daniel et al. Sep 2003 B2
6623500 Cook et al. Sep 2003 B1
6626901 Treat et al. Sep 2003 B1
6647281 Morency Nov 2003 B2
6650091 Shiue et al. Nov 2003 B1
6650975 Ruffner Nov 2003 B2
6656177 Truckai et al. Dec 2003 B2
6658301 Loeb et al. Dec 2003 B2
6666875 Sakurai et al. Dec 2003 B1
6706038 Francischelli et al. Mar 2004 B2
6717193 Olewine et al. Apr 2004 B2
6730042 Fulton et al. May 2004 B2
6753673 Shiue et al. Jun 2004 B2
6758855 Fulton, III et al. Jul 2004 B2
6761698 Shibata et al. Jul 2004 B2
6761701 Cucin Jul 2004 B2
6783524 Anderson et al. Aug 2004 B2
6815206 Lin et al. Nov 2004 B2
6821671 Hinton et al. Nov 2004 B2
6836097 Turner et al. Dec 2004 B2
6838862 Luu Jan 2005 B2
6847192 Turner et al. Jan 2005 B2
6860880 Treat et al. Mar 2005 B2
6869435 Blake Mar 2005 B2
6923807 Ryan et al. Aug 2005 B2
6982696 Shahoian Jan 2006 B1
6998822 Turner et al. Feb 2006 B2
7031155 Sauciuc et al. Apr 2006 B2
7061749 Liu et al. Jun 2006 B2
7077853 Kramer et al. Jul 2006 B2
7083589 Banko et al. Aug 2006 B2
7085123 Shiue et al. Aug 2006 B2
7101371 Dycus et al. Sep 2006 B2
7112201 Truckai et al. Sep 2006 B2
7125409 Truckai et al. Oct 2006 B2
7150712 Buehlmann et al. Dec 2006 B2
7160132 Phillips et al. Jan 2007 B2
7169146 Truckai et al. Jan 2007 B2
7186253 Truckai et al. Mar 2007 B2
7186473 Shiue et al. Mar 2007 B2
7189233 Truckai et al. Mar 2007 B2
7220951 Truckai et al. May 2007 B2
7221216 Nguyen May 2007 B2
7232440 Dumbauld et al. Jun 2007 B2
7244024 Biscardi Jul 2007 B2
7292227 Fukumoto et al. Nov 2007 B2
7296804 Lechot et al. Nov 2007 B2
7303556 Metzger et al. Dec 2007 B2
7309849 Truckai et al. Dec 2007 B2
7311709 Truckai et al. Dec 2007 B2
7349741 Maltan et al. Mar 2008 B2
7353068 Tanaka et al. Apr 2008 B2
7354440 Truckai et al. Apr 2008 B2
7364061 Swayze et al. Apr 2008 B2
7364554 Bolze et al. Apr 2008 B2
7375644 Miyazawa May 2008 B2
7381209 Truckai et al. Jun 2008 B2
7416101 Shelton, IV et al. Aug 2008 B2
7422139 Shelton, IV et al. Sep 2008 B2
7464846 Shelton, IV et al. Dec 2008 B2
7470237 Beckman et al. Dec 2008 B2
7473145 Her et al. Jan 2009 B2
7479152 Fulton, III et al. Jan 2009 B2
7494492 Da Silva et al. Feb 2009 B2
D594983 Price et al. Jun 2009 S
7560903 Thrap Jul 2009 B2
7563142 Wenger et al. Jul 2009 B1
7570994 Tamura et al. Aug 2009 B2
7573151 Acena et al. Aug 2009 B2
7583564 Ketahara et al. Sep 2009 B2
7638958 Philipp et al. Dec 2009 B2
7643378 Genosar Jan 2010 B2
7658247 Carter Feb 2010 B2
7692411 Trainor et al. Apr 2010 B2
7699850 Miller Apr 2010 B2
7699856 Van Wyk et al. Apr 2010 B2
7717312 Beetel May 2010 B2
7721936 Shalton, IV et al. May 2010 B2
7738971 Swayze et al. Jun 2010 B2
7761198 Bhardwaj Jul 2010 B2
7766910 Hixson et al. Aug 2010 B2
7766929 Masuda Aug 2010 B2
7770722 Donahoe et al. Aug 2010 B2
7770775 Shelton, IV et al. Aug 2010 B2
7776037 Odom Aug 2010 B2
7780660 Bourne et al. Aug 2010 B2
7802121 Zansky et al. Sep 2010 B1
7815658 Murakami Oct 2010 B2
7845537 Shelton, IV et al. Dec 2010 B2
7846155 Houser et al. Dec 2010 B2
7846159 Morrison et al. Dec 2010 B2
7889489 Richardson et al. Feb 2011 B2
7918848 Lau et al. Apr 2011 B2
7922063 Zemlok et al. Apr 2011 B2
7923151 Lam et al. Apr 2011 B2
7948208 Partovi et al. May 2011 B2
7952322 Partovi et al. May 2011 B2
7952873 Glahn et al. May 2011 B2
7959050 Smith et al. Jun 2011 B2
7977921 Bahai et al. Jul 2011 B2
7982439 Trainor et al. Jul 2011 B2
8038025 Stark et al. Oct 2011 B2
8040107 Ishii Oct 2011 B2
8052605 Muller et al. Nov 2011 B2
8058771 Giordano et al. Nov 2011 B2
8075530 Taylor et al. Dec 2011 B2
8083120 Shelton et al. Dec 2011 B2
8097011 Hideo et al. Jan 2012 B2
8142461 Houser et al. Mar 2012 B2
8147488 Masuda Apr 2012 B2
8177776 Humayun et al. May 2012 B2
8179103 Doljack May 2012 B2
8195271 Rahn Jun 2012 B2
8210411 Yates et al. Jul 2012 B2
8216212 Grant et al. Jul 2012 B2
8221418 Prakash et al. Jul 2012 B2
8240498 Ramsey et al. Aug 2012 B2
8246642 Houser et al. Aug 2012 B2
8251994 McKenna et al. Aug 2012 B2
8267094 Danek et al. Sep 2012 B2
8277446 Heard Oct 2012 B2
8292888 Whitman Oct 2012 B2
8298253 Charles Oct 2012 B2
8301262 Mi et al. Oct 2012 B2
8323271 Humayun et al. Dec 2012 B2
8328732 Parihar et al. Dec 2012 B2
8328802 Deville et al. Dec 2012 B2
8333764 Francischelli et al. Dec 2012 B2
8336725 Ramsey et al. Dec 2012 B2
8337097 Cao Dec 2012 B2
8344690 Smith et al. Jan 2013 B2
8372099 Deville et al. Feb 2013 B2
8377059 Deville et al. Feb 2013 B2
8400108 Powell et al. Mar 2013 B2
8403948 Deville et al. Mar 2013 B2
8403949 Palmer et al. Mar 2013 B2
8403950 Palmer et al. Mar 2013 B2
8419757 Smith et al. Apr 2013 B2
8419758 Smith et al. Apr 2013 B2
8425545 Smith et al. Apr 2013 B2
8444653 Nycz et al. May 2013 B2
8444662 Palmer et al. May 2013 B2
8449529 Bek et al. May 2013 B2
8459520 Giordano et al. Jun 2013 B2
8461744 Wiener et al. Jun 2013 B2
8487487 Dietz et al. Jul 2013 B2
8522795 Bouix et al. Sep 2013 B2
8550106 Hebach et al. Oct 2013 B2
8550981 Woodruff et al. Oct 2013 B2
8551088 Falkenstein et al. Oct 2013 B2
8564242 Hansford et al. Oct 2013 B2
8573461 Shelton et al. Nov 2013 B2
8574253 Gruber et al. Nov 2013 B2
8598852 Gilmore Dec 2013 B2
8602287 Laurent et al. Dec 2013 B2
8608045 Smith et al. Dec 2013 B2
8617077 van Groningen et al. Dec 2013 B2
8622274 Yates et al. Jan 2014 B2
8623027 Price et al. Jan 2014 B2
8632535 Shelton, IV et al. Jan 2014 B2
8636736 Yates et al. Jan 2014 B2
8641629 Kurokawa Feb 2014 B2
8657174 Yates et al. Feb 2014 B2
8663112 Slayton et al. Mar 2014 B2
8733614 Ross et al. May 2014 B2
8758342 Bales et al. Jun 2014 B2
8784415 Malackowski et al. Jul 2014 B2
8808319 Houser et al. Aug 2014 B2
8834465 Ramstein et al. Sep 2014 B2
8864761 Johnson et al. Oct 2014 B2
8906017 Rioux et al. Dec 2014 B2
8939974 Boudreaux et al. Jan 2015 B2
8961441 Cioanla et al. Feb 2015 B2
8968648 Kaneko Mar 2015 B2
8986302 Boudreaux et al. Mar 2015 B2
8998939 Price et al. Apr 2015 B2
9000720 Stulen et al. Apr 2015 B2
9011336 Slayton et al. Apr 2015 B2
9011427 Price et al. Apr 2015 B2
9011471 Timm et al. Apr 2015 B2
9017849 Stulen et al. Apr 2015 B2
9017851 Felder et al. Apr 2015 B2
9023071 Miller et al. May 2015 B2
9039720 Madan May 2015 B2
9044261 Houser Jun 2015 B2
9050098 Deville et al. Jun 2015 B2
9050125 Boudreaux et al. Jun 2015 B2
9060750 Lam Jun 2015 B2
9072523 Houser et al. Jul 2015 B2
9072543 Miller et al. Jul 2015 B2
9078671 Beale et al. Jul 2015 B2
9089338 Smith et al. Jul 2015 B2
9095346 Houser et al. Aug 2015 B2
9113903 Unger Aug 2015 B2
9161803 Yates et al. Oct 2015 B2
9179912 Yates et al. Nov 2015 B2
9186046 Ramamurthy et al. Nov 2015 B2
9186047 Ramamurthy et al. Nov 2015 B2
9192428 Houser et al. Nov 2015 B2
9247986 Haberstich et al. Feb 2016 B2
9308009 Madan et al. Apr 2016 B2
9318271 Fletcher et al. Apr 2016 B2
9364279 Houser et al. Jun 2016 B2
9364288 Smith et al. Jun 2016 B2
9375255 Houser et al. Jun 2016 B2
9381058 Houser et al. Jul 2016 B2
9408575 Bordoley et al. Aug 2016 B2
9820738 Lytle et al. Nov 2017 B2
10004497 Overmyer et al. Jun 2018 B2
10376304 Houser et al. Aug 2019 B2
10537380 Houser et al. Jan 2020 B2
20010032666 Jenson et al. Oct 2001 A1
20020165577 Witt et al. Nov 2002 A1
20030093103 Malackowski et al. May 2003 A1
20030109802 Laeseke et al. Jun 2003 A1
20030114851 Truckai et al. Jun 2003 A1
20030144680 Kellogg et al. Jul 2003 A1
20030216723 Shinmura Nov 2003 A1
20040097911 Murakami et al. May 2004 A1
20040116952 Sakurai et al. Jun 2004 A1
20040133189 Sakurai Jul 2004 A1
20040173487 Johnson et al. Sep 2004 A1
20050021065 Yamada et al. Jan 2005 A1
20050033195 Fulton, III et al. Feb 2005 A1
20050171522 Christopherson Aug 2005 A1
20050203546 Van Wyk et al. Sep 2005 A1
20060030797 Zhou et al. Feb 2006 A1
20060079829 Fulton, III et al. Apr 2006 A1
20060079874 Faller et al. Apr 2006 A1
20060079877 Houser et al. Apr 2006 A1
20060079879 Faller et al. Apr 2006 A1
20060253176 Caruso et al. Nov 2006 A1
20070027447 Theroux et al. Feb 2007 A1
20070078484 Talarico et al. Apr 2007 A1
20070103437 Rosenberg May 2007 A1
20070191713 Eichmann et al. Aug 2007 A1
20070207354 Curello et al. Sep 2007 A1
20070261978 Sanderson Nov 2007 A1
20070265613 Edelstein et al. Nov 2007 A1
20070265620 Kraas et al. Nov 2007 A1
20070282333 Fortson et al. Dec 2007 A1
20070290654 Govari Dec 2007 A1
20080003491 Yahnker et al. Jan 2008 A1
20080004656 Livneh Jan 2008 A1
20080057470 Levy et al. Mar 2008 A1
20080147058 Horrell et al. Jun 2008 A1
20080150754 Quendt Jun 2008 A1
20080164842 Bergner Jul 2008 A1
20080173651 Ping Jul 2008 A1
20080188810 Larsen et al. Aug 2008 A1
20080200940 Eichmann et al. Aug 2008 A1
20080228104 Uber, II et al. Sep 2008 A1
20080255413 Zemlok et al. Oct 2008 A1
20080281301 Deboer et al. Nov 2008 A1
20080315829 Jones et al. Dec 2008 A1
20090043797 Dorie et al. Feb 2009 A1
20090076506 Baker Mar 2009 A1
20090096430 Van Der Linde et al. Apr 2009 A1
20090143799 Smith et al. Jun 2009 A1
20090143800 Deville et al. Jun 2009 A1
20090253030 Kooij Oct 2009 A1
20090281430 Wilder Nov 2009 A1
20100021022 Pittel et al. Jan 2010 A1
20100030218 Prevost Feb 2010 A1
20100060231 Trainor et al. Mar 2010 A1
20100076455 Birkenbach et al. Mar 2010 A1
20100106144 Matsumura et al. Apr 2010 A1
20100106146 Boitor et al. Apr 2010 A1
20100125172 Jayaraj May 2010 A1
20100145146 Melder Jun 2010 A1
20100152610 Parihar et al. Jun 2010 A1
20100201311 Alexander et al. Aug 2010 A1
20100249665 Roche Sep 2010 A1
20100268221 Beller et al. Oct 2010 A1
20100274160 Yachi et al. Oct 2010 A1
20110009694 Schultz et al. Jan 2011 A1
20110074336 Miller Mar 2011 A1
20110077514 Ulric et al. Mar 2011 A1
20110080134 Miller Apr 2011 A1
20110121049 Malinouskas et al. May 2011 A1
20110181238 Soar Jul 2011 A1
20110221398 Ferber Sep 2011 A1
20120111591 Shelton, IV et al. May 2012 A1
20120116260 Johnson et al. May 2012 A1
20120116261 Mumaw et al. May 2012 A1
20120116262 Houser et al. May 2012 A1
20120116263 Houser et al. May 2012 A1
20120116265 Houser et al. May 2012 A1
20120116266 Houser et al. May 2012 A1
20120116267 Kimball et al. May 2012 A1
20120116366 Houser et al. May 2012 A1
20120116380 Madan et al. May 2012 A1
20120116381 Houser et al. May 2012 A1
20120116388 Houser et al. May 2012 A1
20120116389 Houser et al. May 2012 A1
20120116391 Houser et al. May 2012 A1
20120179036 Patrick et al. Jul 2012 A1
20120292367 Morgan et al. Nov 2012 A1
20120305427 Felder et al. Dec 2012 A1
20130085330 Ramamurthy et al. Apr 2013 A1
20130085332 Ramamurthy et al. Apr 2013 A1
20130085397 Ramamurthy et al. Apr 2013 A1
20130090528 Ramamurthy et al. Apr 2013 A1
20130090552 Ramamurthy et al. Apr 2013 A1
20130090675 Mumaw et al. Apr 2013 A1
20130118733 Kumar May 2013 A1
20140088739 Ellis et al. Mar 2014 A1
20150305763 Houser et al. Oct 2015 A1
20160121143 Mumaw et al. May 2016 A1
20160206900 Haberstich et al. Jul 2016 A1
20160329614 Madan et al. Nov 2016 A1
20160338760 Houser et al. Nov 2016 A1
20170245913 Houser et al. Aug 2017 A1
20180055559 Shelton, IV et al. Mar 2018 A1
Foreign Referenced Citations (59)
Number Date Country
101683281 Mar 2010 CN
101819334 Apr 2013 CN
102008051866 Oct 2010 DE
102009013034 Oct 2010 DE
0897696 Feb 1999 EP
0947167 Oct 1999 EP
1330991 Jul 2003 EP
1525853 Apr 2005 EP
1535585 Jun 2005 EP
1684396 Jul 2006 EP
1721576 Nov 2006 EP
1743592 Jan 2007 EP
1818021 Aug 2007 EP
1839599 Oct 2007 EP
1868275 Dec 2007 EP
1886637 Feb 2008 EP
1943976 Jul 2008 EP
1970014 Sep 2008 EP
1997439 Dec 2008 EP
2027819 Feb 2009 EP
2090256 Aug 2009 EP
2105104 Sep 2009 EP
2165660 Mar 2010 EP
2218409 Aug 2010 EP
2243439 Oct 2010 EP
2345454 Jul 2011 EP
2425874 Nov 2006 GB
2440566 Feb 2008 GB
H 01-268370 Oct 1989 JP
H 10-308907 Nov 1998 JP
2002-336265 Nov 2002 JP
2005-033868 Feb 2005 JP
2010-518978 Jun 2010 JP
5410110 Feb 2014 JP
WO 1997024072 Jul 1997 WO
WO 2000065682 Feb 2000 WO
WO 2003013374 Feb 2003 WO
WO 2003020139 Mar 2003 WO
WO 2004113991 Dec 2004 WO
WO 2005079915 Sep 2005 WO
WO 2006023266 Mar 2006 WO
WO 2007004515 Jan 2007 WO
WO 2007024983 Mar 2007 WO
WO 2007050439 May 2007 WO
WO 2007090025 Aug 2007 WO
WO 2007137115 Nov 2007 WO
WO 2007137304 Nov 2007 WO
WO 2008071898 Jun 2008 WO
WO 2008102154 Aug 2008 WO
WO 2008107902 Sep 2008 WO
WO 2008131357 Oct 2008 WO
WO 2009018409 Feb 2009 WO
WO 2009046394 Apr 2009 WO
WO 2009070780 Jun 2009 WO
WO 2009073608 Jun 2009 WO
WO 2010030850 Mar 2010 WO
WO 2010096174 Aug 2010 WO
WO 2011059785 May 2011 WO
WO 2011089270 Jul 2011 WO
Non-Patent Literature Citations (220)
Entry
Dietz, T. et al., Partially Implantable Vibrating Ossicular Prosthesis, Transducers'97, vol. 1, International Conference on Solid State Sensors and Actuators, (Jun. 16-19, 1997) pp. 433-436 (Abstract).
“System 6 Aseptic Battety System,” Stryker (2006) pp. 1-2.
Australian First Examination Report dated May 18, 2015 for Application No. 2011323284.
Chinese Office Action dated Jan. 29, 2015 for Application No. 2011800640106.
Chinese Office Action dated Jan. 29, 2015 for Application No. 2011800638159.
Chinese Office Action dated Feb. 2, 2015 for Application No. 2011800534501.
Chinese First Office Action dated Feb. 2, 2015 for App. No. CN 2011800641490.
Chinese First Office Action dated Feb. 16, 2015 for App. No. CN 2011800638356.
Chinese Office Action dated Feb. 16, 2015 for Application No. 2011800638286.
Chinese First Office Action dated Feb. 28, 2015 for App No. CN 2011800641471.
Chinese Office Action dated Mar. 4, 2015 for Application No. 201180063595.X.
Chinese Office Action dated Mar. 30, 2015 for Application No. 2011800639823.
Chinese Office Action dated Mar. 27, 2015 for Application No. 2011800638214.
Chinese First Office Action dated Apr. 16, 2015 for App. No. CN 201180063919X.
Chinese Office Action dated Apr. 20, 2015 for Application No. 2011800534342.
Chinese Office Action dated Oct. 8, 2016 for Application No. 2011800534342.
Chinese Search Report dated Oct. 8, 2016 for App. No. CN 2011800534342.
Chinese Third Office Action dated Oct. 17, 2016 for App. No. CN 2011800534342.
Chinese Office Action dated 17/17/16 for Application No. 2011800534342.
Chinese Office Action dated Aug. 28, 2015 for Application No. 2011800640106.
EP Communication dated Feb. 19, 2014 for Application No. EP 11781972.2.
Indian Office Action, Examination Report, dated Mar. 28, 2018 for Application No. 4008/DELNP/2013, 6 pgs.
Indian Office Action, Examination Report, dated Jun. 13, 2019 for Application No. 3973/DELNP/2013, 6 pgs.
International Search Report and Written Opinion dated Jan. 26, 2012for Application No. PCT/US2011/059212.
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059212.
Communication from International Searching Authority dated Jan. 24, 2012 for Application No. PCT/US2011/059215.
International Search Report dated Apr. 4, 2012 for Application No. PCT/US2011/059215.
International Preliminary Report on Patentability dated May 8, 2013 for Application No. PCT/US2011/059215.
International Search Report dated Feb. 13, 2012for Application No. PCT/US2011/059217.
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059217.
International Search Report dated Jun. 12, 2012 for Application No. PCT/US2011/059218.
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCY/US2011/059218.
International Search Report dated Jan. 26, 2012 for Application No. PCT/US11/059220.
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059220.
Communication from International Searching Authority dated Feb. 2, 2012for Application No. PCT/US2011/059222.
International Search Report dated Apr. 18, 2012 for Application No. PCT/US2011/059222.
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059222.
International Search Report dated Feb. 1, 2012 for Application No. PCT/US11/059223.
International Preliminary Report on Patentability dated Feb. 1, 2012 for Application No. PCT/US2011/059223.
International Search Report dated Jan. 12, 2012 for Application No. PCT/US11/059226.
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059226.
International Search Report dated Mar. 15, 2012 for Application No. PCT/US2011/059338.
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059338.
International Search Report dated Feb. 7, 2012 for Application No. PCT/US2011/059351.
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059351.
International Search Report dated Feb. 2, 2012for Application No. PCT/US2011/059354.
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059354.
International Search Report dated May 29, 2012 for Application No. PCT/US11/059358.
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059358.
Communication from International Searching Authority dated Feb. 6, 2012for Application No. PCT/US2011/059362.
International Search Report dated Aug. 22, 2012for Application No. PCT/US2011/059362.
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059362.
International Search Report dated Jun. 4, 2012 for Application No. PCT/US2011/059365.
International Preliminary Report on Patentability dated May 8, 2013 for Application No. PCT/US2011/059365.
International Search Report dated Feb. 23, 2012 for Application No. PCT/US2011/059371.
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059371.
Communication from International Searching Authority dated Feb. 2, 2012 for Application No. PCT/US2011/059378.
International Search Report dated May 24, 2012 for Application No. PCT/US2011/059378.
International Search Report and Written Opinion dated Feb. 2, 2012for Application No. PCT/US2011/059378.
International Preliminary Report on Patentability dated May 7, 2013 for Application No. PCT/US2011/059378.
International Search Report dated Apr. 11, 2012 for Application No. PCT/US2011/059381.
International Search Report and Written Opinion dated Jul. 6, 2012 for PCT/US2011/059381.
International Preliminary Report on Patentability dated May 8, 2013 for Application No. PCT/US2011/059381.
Japanese Office Action, Notification of Reasons for Refusal, dated Sep. 1, 2015 for Application No. 2013-537837.
Japanese Office Action, Notification of Reasons for Refusal, dated Feb. 16, 2016 for Application No. 2013-537837.
Japanese Office Action, Pretrial Examination Report, dated Aug. 2, 2016 for Application No. 2013-537837.
Japanese Office Action, Notification of Reasons for Refusal, dated Sep. 1, 2015 for Application No. 2013-537866.
Japanese Office Action, Notification of Reasons for Refusal, dated Jun. 28, 2016 for Application No. 2013-537866.
Japanese Office Action, Examiner's Decision of Refusal, dated Sep. 13, 2016 for Application No. 2013-537869.
Japanese Office Action, Notification of Reasons for Refusal, dated Oct. 6, 2015 for Application No. 2013-537869.
Office Action Non-Final dated Aug. 6, 2013 for U.S. Appl. No. 13/151,471.
Notice of Allowance dated Dec. 6, 2013 for U.S. Appl. No. 13/151,471.
Office Action Non-Final dated Mar. 28, 2014 for U.S. Appl. No. 13/151,471.
U.S. Office Action, Notice of Allowance, dated Aug. 19, 2014 for U.S. Appl. No. 13/151,471.
U.S. Office Action, Notice of Allowance, dated Nov. 21, 2014 for U.S. Appl. No. 13/151,471.
Restriction Requirement dated Dec. 11, 2012 for U.S. Appl. No. 13/151,481.
Office Action Non-Final dated Feb. 15, 2013 for U.S. Appl. No. 13/151,481.
Office Action Final dated Jun. 7, 2013 for U.S. Appl. No. 13/151,481.
U.S. Office Action, Non-Final, dated Aug. 14, 2014 for U.S. Appl. No. 13/151,481.
U.S. Office Action, Final, dated Apr. 1, 2015 for U.S. Appl. No. 13/151,481.
U.S. Office Action, Notice of Allowance, dated Jun. 10, 2015 for U.S. Appl. No. 13/151,481.
Restriction Requirement dated Jul. 5, 2013 for U.S. Appl. No. 13/151,488.
U.S. Office Action, Non-Final, dated Nov. 7, 2014 for U.S. Appl. No. 13/151,488.
U.S. Office Action, Final, dated Jul. 17, 2015 for U.S. Appl. No. 13/151,488.
Office Action Non-Final dated Jun. 14, 2013 for U.S. Appl. No. 13/151,498.
Office Action Final dated Nov. 21, 2013 for U.S. Appl. No. 13/151,498.
Office Action Non-Final dated Mar. 18, 2014 for U.S. Appl. No. 13/151,498.
U.S. Office Action, Notice of Allowance, dated Aug. 6, 2014 for U.S. Appl. No. 13/151,498.
U.S. Office Action, Notice of Allowance, dated Nov. 21, 2014 for U.S. Appl. No. 13/151,498.
U.S. Office Action, Non-Final, dated Jun. 18, 2014 for U.S. Appl. No. 13/151,503.
U.S. Office Action, Non-Final, dated Nov. 6, 2014 for U.S. Appl. No. 13/151,503.
U.S. Office Action, Final, dated Jun. 8, 2015 for U.S. Appl. No. 13/151,503.
U.S. Office Action, Non-Final, dated Oct. 2, 2015 for U.S. Appl. No. 13/151,503.
U.S. Office Action, Final, dated Mar. 9, 2016 for U.S. Appl. No. 13/151,503.
U.S. Office Action, Notice of Allowance, dated Jul. 27, 2016 for U.S. Appl. No. 13/151,503.
U.S. Office Action, Notice of Allowance, dated Nov. 2, 2016 for U.S. Appl. No. 13/151,503.
Restriction Requirement dated Mar. 13, 2013 for U.S. Appl. No. 13/151,509.
Restriction Requirement dated Jun. 24, 2013 for U.S. Appl. No. 13/151,509.
Office Action Non-Final dated Sep. 26, 2013 for U.S. Appl. No. 13/151,509.
Office Action Final dated Jan. 29, 2014 for U.S. Appl. No. 13/151,509.
Office Action Non-Final dated Jul. 9, 2014 for U.S. Appl. No. 13/151,509.
U.S. Office Action, Notice of Allowance, dated Oct. 28, 2014 for U.S. Appl. No. 13/151,509.
U.S. Office Action, Notice of Allowance, dated Feb. 25, 2015 for U.S. Appl. No. 13/151,509.
Restriction Requirement dated Jun. 11, 2014 for U.S. Appl. No. 13/151,512.
U.S. Office Action, Notice of Allowance, dated Oct. 29, 2014 for U.S. Appl. No. 13/151,512.
U.S. Office Action, Notice of Allowance, dated Feb. 17, 2015 for U.S. Appl. No. 13/151,512.
U.S. Office Action, Restriction Requirement, dated Jul. 11, 2014 for U.S. Appl. No. 13/269,870.
U.S. Office Action, Non-Final, dated Jan. 5, 2015 for U.S. Appl. No. 13/269,870.
Restriction Requirement dated Feb. 28, 2013 for U.S. Appl. No. 13/270,667.
Office Action Non-Final dated Apr. 26, 2013 for U.S. Appl. No. 13/270,667.
Office Action Final dated Oct. 25, 2013 for U.S. Appl. No. 13/270,667.
U.S. Office Action, Non-Final, dated Jul. 29, 2014 for U.S. Appl. No. 13/270,667.
U.S. Office Action, Notice of Allowance, dated Dec. 17, 2014 for U.S. Appl. No. 13/270,667.
U.S. Office Action, Restriction Requirement, dated Jul. 9, 2014 for U.S. Appl. No. 13/270,684.
U.S. Office Action, Non-Final, dated Oct. 9, 2014 for U.S. Appl. No. 13/270,684.
U.S. Office Action, Final, dated Mar. 7, 2015 for U.S. Appl. No. 13/270,684.
U.S. Office Action, Notice of Allowance, dated Jul. 28, 2015 for U.S. Appl. No. 13/270,684.
U.S. Office Action, Restriction Requirement, dated Sep. 11, 2014 for U.S. Appl. No. 13/270,701.
U.S. Office Action, Non-Final, dated Dec. 16, 2014 for U.S. Appl. No. 13/270,701.
U.S. Office Action, Final, dated Jun. 17, 2015 for U.S. Appl. No. 13/270,701.
Office Action Non-Final dated Nov. 21, 2013 for U.S. Appl. No. 13/271,352.
U.S. Office Action, Restriction Requirement, dated Sep. 25, 2014 for U.S. Appl. No. 13/271,352.
U.S. Office Action, Non-Final, dated Mar. 26, 2015 for U.S. Appl. No. 13/271,352.
U.S. Office Action, Final, dated Jul. 15, 2015 for U.S. Appl. No. 13/271,352.
U.S. Office Action, Restriction Requirement, dated Feb. 25, 2015 for U.S. Appl. No. 13/271,364.
U.S. Office Action, Non-Final, dated Jul. 14, 2015 for U.S. Appl. No. 13/271,364.
U.S. Office Action, Restriction Requirement, dated Oct. 2, 2013 for U.S. Appl. No. 13/274,480.
Office Action Non-Final dated Feb. 14, 2014 for U.S. Appl. No. 13/274,480.
U.S. Office Action, Final, dated Jul. 17, 2014 for U.S. Appl. No. 13/274,480.
U.S. Office Action, Non-Final, dated May 1, 2015 for U.S. Appl. No. 13/274,480.
Restriction Requirement dated Dec. 9, 2013 for U.S. Appl. No. 13/274,496.
Office Action Non-Final dated Feb. 6, 2014 for U.S. Appl. No. 13/274,496.
Office Action Final dated May 15, 2014 for U.S. Appl. No. 13/274,496.
U.S. Office Action, Final, dated Aug. 22, 2014 for U.S. Appl. No. 13/274,496.
U.S. Office Action, Non-Final, dated Apr. 2, 2015 for U.S. Appl. No. 13/274,496.
Restriction Requirement dated Mar. 28, 2014 for U.S. Appl. No. 13/274,507.
Office Action Non-Final dated Jun. 19, 2014 for U.S. Appl. No. 13/274,507.
U.S. Office Action, Non-Final, dated Jul. 22, 2015 for U.S. Appl. No. 13/274,507.
Office Action Non-Final dated Dec. 21, 2012 for U.S. Appl. No. 13/274,516.
Office Action Final dated Aug. 16, 2013 for U.S. Appl. No. 13/274,516.
Office Action Non-Final dated Dec. 6, 2013 for U.S. Appl. No. 13/274,516.
U.S. Office Action, Final, dated Jun. 12, 2014 for U.S. Appl. No. 13/274,516.
U.S. Office Action, Non-Final, dated Oct. 8, 2014 for U.S. Appl. No. 13/274,516.
U.S. Office Action, Final, dated May 8, 2015 for U.S. Appl. No. 13/274,516.
Restriction Requirement dated Feb. 25, 2013 for U.S. Appl. No. 13/274,540.
Office Action Non-Final dated Apr. 30, 2013 for U.S. Appl. No. 13/274,540.
Office Action Final dated Oct. 25, 2013 for U.S. Appl. No. 13/274,540.
U.S. Office Action. Non-Final, dated Aug. 26, 2014 for U.S. Appl. No. 13/274,540.
U.S. Office Action, Notice of Allowance, dated Jan. 21, 2015 for U.S. Appl. No. 13/274,540.
Office Action Non-Final dated Apr. 1, 2013 for U.S. Appl. No. 13/274,805.
Office Action Final dated Sep. 12, 2013 for U.S. Appl. No. 13/274,805.
U.S. Office Action, Non-Final, dated Aug. 14, 2014 for U.S. Appl. No. 13/274,805.
U.S. Office Action, Notice of Allowance, dated Nov. 28, 2014 for U.S. Appl. No. 13/274,805.
U.S. Office Action, Notice of Allowance, dated Jan. 21, 2015 for U.S. Appl. No. 13/274,805.
Restriction Requirement dated Apr. 29, 2013 for U.S. Appl. No. 13/274,830.
Office Action Non-Final dated Jun. 14, 2013 for U.S. Appl. No. 13/274,830.
Office Action Final dated Nov. 26, 2013 for U.S. Appl. No. 13/274,830.
U.S. Office Action, Non-Final, dated Oct. 22, 2014 for U.S. Appl. No. 13/274,830.
U.S. Office Action, Notice of Allowance, dated Mar. 23, 2015 for U.S. Appl. No. 13/274,830.
U.S. Office Action, Notice of Allowance, dated Jul. 9, 2015 for U.S. Appl. No. 13/274,830.
Restriction Requirement dated Apr. 4, 2013 for U.S. Appl. No. 13/275,495.
Office Action Non-Final dated May 31, 2013 for U.S. Appl. No. 13/275,495.
Office Action Final dated Dec. 5, 2013 for U.S. Appl. No. 13/275,495.
U.S. Office Action, Non-Final, dated Feb. 25, 2015 for U.S. Appl. No. 13/275,495.
U.S. Office Action, Final, dated May 27, 2015 for U.S. Appl. No. 13/275,495.
U.S. Office Action, Non-Final, dated Jun. 6, 2016 for U.S. Appl. No. 13/275,495.
U.S. Office Action, Final, dated Dec. 21, 2016 for U.S. Appl. No. 13/275,495.
Office Action Non-Final dated Jan. 6, 2014 for U.S. Appl. No. 13/275,514.
U.S. Office Action, Non-Final, dated Sep. 9, 2014 for U.S. Appl. No. 13/275,514.
U.S. Office Action, Non-Final, dated May 21, 2015 for U.S. Appl. No. 13/275,514.
U.S. Office Action, Final, dated Sep. 11, 2015 for U.S. Appl. No. 13/275,514.
U.S. Office Action, Notice of Allowance, dated Nov. 25, 2015 for U.S. Appl. No. 13/275,514.
U.S. Office Action, Notice of Allowance, dated Mar. 2, 2016 for U.S. Appl. No. 13/275,514.
Office Action Non-Final dated May 17, 2013 for U.S. Appl. No. 13/275,547.
Office Action Final dated Feb. 28, 2014 for U.S. Appl. No. 13/275,547.
U.S. Office Action, Non-Final, dated Aug. 20, 2014 for U.S. Appl. No. 13/275,547.
U.S. Office Action, Final, dated Mar. 10, 2015 for U.S. Appl. No. 13/275,547.
U.S. Office Action, Non-Final, dated Aug. 28, 2015 for U.S. Appl. No. 13/275,547.
U.S. Office Action, Final, dated May 6, 2016 for U.S. Appl. No. 13/275,547.
Office Action Non-Final dated Feb. 1, 2013 for U.S. Appl. No. 13/275,563.
Office Action Final dated Aug. 29, 2013 for U.S. Appl. No. 13/275,563.
U.S. Office Action, Non-Final, dated Oct. 23, 2014 for U.S. Appl. No. 13/275,563.
U.S. Office Action, Non-Final, dated May 28, 2015 for U.S. Appl. No. 13/275,563.
Restriction Requirement dated Feb. 6, 2013 for U.S. Appl. No. 13/276,660.
Office Action Non-Final dated Jun. 3, 2013 for U.S. Appl. No. 13/246,660.
U.S. Office Action, Restriction Requirement, dated Jul. 9, 2014 for U.S. Appl. No. 13/276,660.
U.S. Office Action, Notice of Allowance, dated Jun. 17, 2015 for U.S. Appl. No. 13/276,660.
Office Action Non-Final dated Dec. 21, 2012 for U.S. Appl. No. 13/276,673.
Office Action Non-Final dated Aug. 19, 2013 for U.S. Appl. No. 13/276,673.
Office Action Final dated Mar. 21, 2014 for U.S. Appl. No. 13/276,673.
U.S. Office Action, Non-Final, dated Aug. 14, 2014 for U.S. Appl. No. 13/276,673.
U.S. Office Action, Final, dated Mar. 13, 2015 for U.S. Appl. No. 13/276,673.
Restriction Requirement dated Feb. 6, 2013 for U.S. Appl. No. 13/276,687.
Office Action Non-Final dated Jun. 12, 2013 for U.S. Appl. No. 13/276,687.
Notice of Allowance dated Nov. 12, 2013 for U.S. Appl. No. 13/276,687.
Notice of Allowance dated Jun. 2, 2014 for U.S. Appl. No. 13/276,687.
U.S. Office Action, Notice of Allowance, dated Sep. 12, 2014 for U.S. Appl. No. 13/276,687.
U.S. Office Action, Notice of Allowance, dated Dec. 23, 2014 for U.S. Appl. No. 13/276,687.
Restriction Requirement dated Feb. 21, 2013 for U.S. Appl. No. 13/276,707.
Office Action Non-Final dated May 6, 2013 for U.S. Appl. No. 13/276,707.
Office Action Final dated Sep. 27, 2013 for U.S. Appl. No. 13/276,707.
U.S. Office Action, Non-Final, dated Jan. 29, 2015 for U.S. Appl. No. 13/276,707.
U.S. Office Action, Non-Final, dated Jul. 16, 2015 for U.S. Appl. No. 13/276,707.
Restriction Requirement dated Feb. 6, 2013 for U.S. Appl. No. 13/276,725.
U.S. Office Action, Non-Final, dated Aug. 20, 2014 for U.S. Appl. No. 13/276,725.
U.S. Office Action, Notice of Allowance, dated Mar. 13, 2015 for U.S. Appl. No. 13/276,725.
Restriction Requirement dated Dec. 21, 2012 for U.S. Appl. No. 13/276,745.
Office Action Non-Final dated Apr. 30, 2013 for U.S. Appl. No. 13/276,745.
Office Action Final dated Nov. 8, 2013 for U.S. Appl. No. 13/276,745.
Office Action Non-Final dated Feb. 28, 2014 for U.S. Appl. No. 13/276,745.
U.S. Office Action, Notice of Allowance, dated Oct. 7, 2014 for U.S. Appl. No. 13/276,745.
U.S. Office Action, Notice of Allowance, dated Dec. 19, 2014 for U.S. Appl. No. 13/276,745.
U.S. Office Action, Restriction Requirement, dated Sep. 24, 2014 for U.S. Appl. No. 13/277,328.
U.S. Office Action, Non-Final, dated Dec. 8, 2014 for U.S. Appl. No. 13/277,328.
U.S. Office Action, Final, dated Mar. 24, 2015 for U.S. Appl. No. 13/277,328.
U.S. Office Action, Notice of Allowance, dated Jun. 1, 2015 for U.S. Appl. No. 13/277,328.
Indian Office Action, Examination Report, dated Oct. 22, 2019 for Application No. 3968/DELNP/2013, 7 pgs.
Indian Office Action, Examination Report, dated Nov. 30, 2019 for Application No. 4013/DELNP/2013, 6pgs.
Indian Office Action, Examination Report, dated Jul. 12, 2019 for Application No. 3960/DELNP/2013, 8 pgs.
U.S. Appl. No. 16/549,798, filed Aug. 23, 2019, by Houser et al., entitled: “Surgical Instrument With Charging Station and Wireless Communication.”
Related Publications (1)
Number Date Country
20200229863 A1 Jul 2020 US
Provisional Applications (2)
Number Date Country
61487846 May 2011 US
61410603 Nov 2010 US
Continuations (2)
Number Date Country
Parent 15212423 Jul 2016 US
Child 16779748 US
Parent 13151503 Jun 2011 US
Child 15212423 US